Tags: AS | SKorea | Samsung Biologics

Regulator: Samsung Biologics Violated Accounting Rules

Thursday, 12 July 2018 04:38 AM

SEOUL, South Korea (AP) — A South Korean regulator says Samsung Biologics has intentionally breached accounting rules.

The Financial Services Commission said Thursday that it will bring the case to prosecutors and ask Samsung Biologics to dismiss executives in charge of accounting breaches.

It says the company has failed to notify investors of crucial information related to its joint venture agreement with Biogen, a U.S. biotechnology company. The missing information affected the valuation of its subsidiary.

The commission says Samsung Biologics was aware that leaving out such information could constitute a violation of accounting rules.

Samsung officials did not respond to messages seeking comments. It has earlier denied the allegation.

Samsung Biologics is a contract drug making affiliate of Samsung Electronics and Samsung C&T.

© Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


   
1Like our page
2Share
GlobalTalk
A South Korean regulator says Samsung Biologics has intentionally breached accounting rules.The Financial Services Commission said Thursday that it will bring the case to prosecutors and ask Samsung Biologics to dismiss executives in charge of accounting breaches.It says...
AS,SKorea,Samsung Biologics
123
2018-38-12
Thursday, 12 July 2018 04:38 AM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved